| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $226K | +0.0% |
| R&D Expense | $11.4M | +0.2% |
| SG&A Expense | $9.1M | +7.7% |
| Operating Income | -$20.3M | -3.4% |
| Pre-tax Income | -$18.9M | +0.1% |
| Net Income | -$18.9M | +0.1% |
| EPS (Basic) | -$0.90 | +1.1% |
| EPS (Diluted) | -$0.90 | +1.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.6M | -46.6% |
| Accounts Receivable | $18K | -37.9% |
| Current Assets | $22.7M | -42.4% |
| Total Assets | $22.7M | -42.4% |
| Current Liabilities | $9.2M | +14.6% |
| Total Liabilities | $12.0M | +8.6% |
| Stockholders' Equity | $10.7M | -62.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.9M | -10.1% |
| Capital Expenditures | $14K | — |
| Investing Cash Flow | -$14K | — |
| Free Cash Flow | -$17.9M | — |